3XT

EXCO TECHS LTD

Consumer Cyclical · EUR · F

3XT

Price

€4.56

-0.98%

Cap

€279.64M

Earnings

30d Trend

-1.3%

3XT
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range65%
€3.77€4.99

Upper half of range — momentum is positive

VolatilityModerate

25% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level30
Quality56
Momentum63
Technical55
Fundamentals83

Raw weighted: 63×Macro 0.99 (1%)=62

RISK LEVEL

30/100
90d Volatility
25.0%Moderate
ATR %
2.1%Normal
Max Drawdown (1Y)
-9.1%Resilient

QUALITY

56/100
ROE (avg)
6.3%Weak
Piotroski F-Score
5/9Average
Debt/Equity
0.24Low leverage
Margin Stability
CV 7.2%Stable
Accruals
-6.8%Cash earnings
Interest Coverage
6.7xAdequate

MOMENTUM

63/100
6-1M Momentum
+13.5%Positive
1M Return
+3.9%Stable
Relative Strength
+0.0% vs sectorIn-line

TECHNICAL

55/100
RSI (14)
56.1Neutral
Price vs SMA200
+11.3%Bullish trend
MACD
0.00Bearish momentum
Bollinger Band
67%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.287Noisy/choppy

FUNDAMENTALS

83/100
EV/EBIT
10.4Cheap
P/FCF
9.4Cheap
P/S
0.5Cheap
Shareholder Yield
7.0%Strong returns

Macro: neutral (×0.99) - Fear/Greed: 61 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months44
3-12 months64
1-5+ years73

12-24 month value thesis — fundamentally underpriced

BRAIN47'S ASSESSMENT

I rate EXCO TECHS LTD at 62/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fundamentals at 83/100. I classify this as a income position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

+3.9%

3 MONTHS

+3.7%

12 MONTHS

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

12-24 month value thesis — fundamentally underpriced. Fundamentals (83) and low-risk profile are the primary strengths. Historical volatility is normal at 25%. I classify this as an income position — the 7.0% yield combined with the dividend profile makes it suitable for income generation.

incomeScore: 62/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.